Skip to search formSkip to main content

YKP 1358

Known as: YKP-1358, YKP1358 
 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (3)

AlkaloidsDopamine D2 Receptor AntagonistsSerotonin 5-HT2 Receptor Antagonists

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Ekonomi Politik: Sengketa Aset Antara Yayasan Kas Pembangunan dengan Pemerintah Kota Surabaya
Awal terbentuknya YKP adalah atas dasar mengamanatkan Undang-undang dasar negara yang pertama, persoalan kesehatan, kedua… Expand
Is this relevant?
2011
2011
The use of healthy volunteers instead of patients to inform drug dosing studies: a [11C]raclopride PET study
RationaleReceptor occupancy study has been performed to evaluate pharmacokinetic profiles in new antipsychotic drug development… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
2011
2011
Calculating Occupancy when One does not have Baseline: A Comparison of Different Options
Dopamine D2 receptor occupancy of antipsychotic drugs is calculated relative to the subject's D2 receptor binding potential (BP… Expand
  • table 1
  • figure 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
2007
2007
Modeling of brain D2 receptor occupancy-plasma concentration relationships with a novel antipsychotic, YKP1358, using serial PET scans in healthy volunteers.
YKP1358 is a novel serotonin (5-HT(2A)) and dopamine (D(2)) antagonist that, in preclinical studies, fits the general profile of… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2006
2006
PII-30PK and D2 receptor occupancy modeling of a novel antipsychotic, YKP1358
 
Is this relevant?
2006
2006
Dopamine D2 receptor occupancy in normal humans treated with a novel antipsychotic drug YKP1358 measured by PET and [11C]raclopride
 
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE